Google Search

Search

Already a Member ?

Pharmaceutical, Drugs, Fine Chemicals, Bulk Drug Intermediates, Pharmaceutical Drugs, Pharma Drug Ingredients Intermediates, Drug Intermediates, Speciality Chemicals, Raw Materials, Fine and Specialty Chemicals Intermediates, Pharmaceutical Bulk Drugs

Indian drugs and pharmaceutical industry has advanced perceptibly and is getting ready  for the new patent regime and  to withstand global competition, which is expected to be unleashed by new winds of liberalisation - a new era of liberalisation - much different from what was ushered in since the conclusion of the Uruguay Round and the establishment of the World Trade Organisation.

The industry has been expanding at annual rates ranging between 8 to 10% (against global growth rate of 6%).  According to a study  by McKinsey, Vision 2010, the domestic pharmaceutical industry could attain a size of  $25 billion (Rs 1200 billion) by 2010 by focusing on two areas: first, innovation-led research, development and new drug discoveries; and second, information technology-led remote sales and marketing.  The market for bulk drugs and formulations had increased from about Rs 103  billion in 1990-91 to an estimated Rs 435  billion at the end of 2003-04.  The prices of Indian essential drugs are among the lowest in the world. Apart from strides made by the industry in the last half-a-century, lower production cost due to reverse engineering and low R&D outlays has been a major factor in keeping the prices under check.

The global pharmaceutical industry is estimated at $ 300 billion, not all representing cross-border trade.  India's measly share of $ 1.5 billion in global trade represents an untapped potential. Under the regime of economic liberalisation underway since early 1990s, the drugs and pharmaceutical sector witnessed initiatives at fresh investment in the sector. Nearly 1735 investment proposals of the order of around Rs 166  billion were initiated. The foreign collaboration proposals approved numbered around 425 with a foreign direct investment  (FDI) component of over Rs 25 billion. The pharmaceuticals have figured high on the export front. In 2001-02,  the sector was  estimated to have registered a growth of 17.6% at around Rs 20.3 billion.

In the wake of economic liberalisation, many a  overseas players  returned or contemplated returning to India. These include Ivox Corp (USA),  Taro Pharmaceuticals (Israel) and Merck (USA). These are out either to set shop or looking for acquisitions in India. Hexal AG of Germany has established a liaison office in India. MILLIONCs like Rocha, Bayer, Aventis and Chiron are making India a regional hub for bulk drugs. 

The Export Import Bank of India (Exim Bank) had  doubled its corpus for the pharmaceutical industry to Rs 2 billion as a result of increased activity in the industry, especially in the external sector. The fund is used for the development and commercialisation of the new products and applications, significant improvement in the existing design of  products, setting up and expansion of pilot plants, research studies for obtaining regulatory approvals, cost of filing and managing international patent and R&D Centres.

It needs, however, to be recognised that the presence  of small scale manufacturers has resulted, on the one hand,  in a highly fragmented industry, and on the other, it has made it possible to supply a near 100,000 drugs including vitamins, antibiotics, antibacterials, cardio-vascular and other essential drugs. These account for nearly 37% of the market.  While each of about 80% of the manufacturers has annual sales below a billion rupees, top ten companies are known to control over 30% of the market. At present there are more than 20,000 players in the country.

The major players are: Alembic Chem, Aurobindo Pharma, Cipla, Dr. Reddy's, FDC, IPCA Labs, Jagsonpal Pharma, J.B. Chemicals, Kopran, Lupin Labs, Lyka Labs, Morepan Labs, Nicholas Piramal, Ranbaxy Labs, Sun Pharma, Themis Medicare, GlaxoSmithkline, Astrazeneca, Aventis, E-Merck, Torrent Pharma, TTK Healthcare, Unichem Labs,  Wockhardt  and  Zandu Pharma.  Until recently, only a few of the Indian companies had gone into any serious R&D activity. Much of the effort was directed to affordable analogue research. The R&D level in the country is low with even well-placed pharma companies spending less than 2% of turnover on R&D. MILLIONCs are known to contribute as much as 10% or more of their turnover to R&D.  While India is very strong in process chemistry, biology and applied bio-chemistry, initiatives at all levels - government, academia, private sector - involving heavy financial outlays, are called for.

Ayurveda continues to remain a preferred system of medicine for a vast segment of population in the country. The country has over 400,000 registered practitioners of the Indian system of medicine. Around 170 institutes properly affiliated to various universities impart under- or post-graduate courses each year. These institutes churn out some 5,500 fresh practitioners. The practitioners are supported by 12,000 dispensaries and 2,100 beds available for ayurveda treatment countrywide. The emerging biotechnology sector has already taken by storm and is offering sops to states to make these as the thriving ground for the highly potential segment in medicare.

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 21 of 21 | Total 201 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 20 21   »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

Empty Hard Gelatin Capsules Manufacturing Industry

Empty Hard Gelatin Capsules Manufacturing Industry. Production of Empty Gel Capsules. Pharmaceutical Capsule Manufacture Gelatin is considered to be animal proteins that are utilized to prepare capsules, which gives calculated quantities of products. Empty hard gelatin capsules are made from gelatin (Gelatin is a translucent, colorless, brittle (when dry), flavorless solid substance, derived from the collagen- an animal protein). Empty Hard Gelatin Capsules contain 12 – 16% moisture. But the moisture content can vary up on the storage conditions. Empty gelatin capsules are available in various colors and color combinations including transparent and metallic capsules. Widely demanded in food, cosmetics and pharmaceutical industry, Empty Hard Gelatin Capsules are used for strengthening bones, improving air quality and various other uses. It is used for filling the solid substance. Features: • Hermetically sealed and airtight • Increase the bio-availability of poorly soluble nutrients • Longer shelf life • Easily digested and dissolved within minutes • Safe to consume • Fast relief Advantage of Gelatin Capsules There are following importance of gelatin capsules: ? It is taste less, odorless and easy to administration. ? They are attractive to appearance. ? Easy to handle and carry. ? Drug having an unpleasant odor and placed in the closed shell. ? Rapid drug release possible. ? Flexibility of formulation • No need to form a compact that must stand up to handling. • Unique mixed fills possible. • Role in drug development. • Role in clinical tests. ? Sealed HGCs are good barriers to atmospheric oxygen. Market Outlook Indian EHGC market is estimated at approx 64 billion capsules in absolute production terms. The global empty capsules market was valued at $1,841.5 million in 2017 and is expected to reach $3,707.5 million by 2025, registering a CAGR of 9.1% from 2018 to 2025. Capsules are relatively stable shells that contain or encapsulate medicines, which are administered in a variety of dosage forms. Empty capsules are of two types in the market namely, gelatin capsules and non-gelatin capsules. Of these, the vegetable/non-gelatin capsules are expected to witness considerable demand in the coming years. This is attributed to the preference for the same among the consumers due to its natural or non-animal origin. The growth of the nutraceuticals industry has provided a shot in the arm to the global empty capsules market. Nutraceuticals have become popular across a range of demographics and regions due to their convenience in complementing a regular diet and help the individual maintain optimum health. The increasing adoption of unhealthy lifestyles by urban consumers across the world, particularly in developed regions, has led to growing demand for nutraceuticals, which is likely to remain a key driver for the global empty capsules market in the coming years. Apart from nutraceuticals, the branching out of the pharmaceuticals industry into the cosmeceuticals sector also has significant potential for the empty capsules market. The demand for capsules is growing on account of the mounting consumption of medicines worldwide. This trend augurs well for the global empty capsules market, where growth has thus far been driven by the demand for both nongelatin and hard gelatin capsules. The changing demographics of the world have necessitated the greater production of medicines to treat various kinds of diseases. Capsules, being among the most versatile forms of administering drug doses, are thus expected to be consumed in larger volumes over the next few years. The consumption demand for empty capsules is shaped by factors like health conditions of the aging population, clinical trial testing of formulations, changing consumer lifestyles, and edible beauty products with specific application in pharma, nutraceutical, and cosmetic industries. The key factors that boost the growth of the global empty capsules market include growth in popularity of capsules over other drug delivery forms and increase in strategic collaborations between empty capsule suppliers and gelatin manufacturers. In addition, rapid advancements in capsule delivery technologies are set to supplement the market growth. However, ethical concerns, price fluctuations regarding gelatin material, and stringent regulations in the pharmaceutical industry are expected to hamper the market growth. Nevertheless, soaring investments by pharmaceutical manufacturers in untapped economies offer profitable opportunities for the expansion of the market. The demand for empty capsules is expected to rise substantially in the years ahead thanks largely to the overall growth and expansion of the global pharmaceuticals industry. Moreover, the greater demand for nutraceuticals will also provide the global capsules market an opportunity to expand as several food supplements and functional foods are encapsulated to make them convenient for on-the-go consumption. The empty capsules market is dominated by top three players, namely, Capsugel (US), ACG Worldwide (India), and Qualicaps (Japan). Some of the other key players in this market are Suheung Co. Ltd. (Korea), CapsCanada Corporation (Canada), Qingdao Yiqing Medicinal Capsules Co., Ltd. (China), Shanxi Guangsheng Medicinal Capsules Co., Ltd (China), Healthcaps India Ltd. (India), Snail Pharma Industry Co. Ltd. (China), Roxlor (US), Sunil Healthcare Ltd. (India), Medi-Caps Ltd. (India), Nectar Lifesciences Ltd. (India), Natural Capsules Ltd. (India), and Bright Pharma Caps Inc. (US). Tags #Hard_Gelatin_Capsules, #Empty_Hard_Gelatin_Capsules, #Gelatin_Capsules, Manufacturing of Empty Hard Gelatin Capsules, #Empty_Hard_Gelatin_Capsules_Manufacture, Hard Gelatin Capsule Manufacturing Process Pdf, Preparation of Empty Gelatin Capsule, Empty Capsules, #Gelatin_Capsule_Manufacture, Capsule Manufacture, Capsule Manufacturing, Empty Gelatin Capsules, #Production_of_Empty_Hard_Gelatin, Manufacture of Hard Gelatin Capsules, Pharmaceutical Capsule Manufacture, Empty Capsules, Empty Gel Capsules, Gelatin Capsule Manufacturing Business, Gelatin Capsule Manufacturing, #How_to_Start_Empty_Gelatin_Capsule_Manufacturing_Business, Hard Gelatin Capsule Manufacturing Plant, Capsule Manufacture, Empty Gelatin Capsule Manufacturing Process, Capsule Production, Hard Gelatin Capsule Manufacturing Process, #Hard_Gelatin_Capsule_Manufacturing_Process_Pdf, Empty Hard Gelatin Capsules Production, Empty Capsule Production, Empty Capsule Making Business, How Empty Gelatin Capsules are Produced, Capsule Manufacturing Process Flow Chart, Manufacturing of Empty Gelatin Capsules, Project Report on Gelatin Capsule Manufacturing Industry, #Detailed_Project_Report_on_Empty_Hard_Gelatin_Capsules_Production, Project Report on Empty Hard Gelatin Capsules Production, Pre-Investment Feasibility Study on Empty Gelatin Capsule Manufacturing Business, Techno-Economic feasibility study on Empty Hard Gelatin Capsules Production, #Feasibility_report_on_Hard_Gelatin_Capsule_Manufacturing_Business, Free Project Profile on Hard Gelatin Capsule Manufacturing Industry, Project profile on Gelatin Capsule Manufacturing, Download free project profile on Empty Hard Gelatin Capsules Production
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 21 of 21 | Total 201 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 .... 20 21   »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Section of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top